RT @CAPR_AACR: From the February issue— PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibilit…
From the February issue— PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study. https://t.co/JLFpntSMOF https://t.co/Q2SUDQbc8N
RT @ECTeamSMH: Read more about the PROTEC trial describing the feasibility of using progesterone therapy for #endometrialcancer prevention…
RT @CAPR_AACR: Recently published #OnlineFirst: PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial— A fe…
RT @ECTeamSMH: Read more about the PROTEC trial describing the feasibility of using progesterone therapy for #endometrialcancer prevention…
RT @ECTeamSMH: Read more about the PROTEC trial describing the feasibility of using progesterone therapy for #endometrialcancer prevention…
Read more about the PROTEC trial describing the feasibility of using progesterone therapy for #endometrialcancer prevention here 👉 https://t.co/tXf2lVegoE #wombcancer #WomensHealth #gynaecancer #CancerResearch
RT @CAPR_AACR: Recently published #OnlineFirst: PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial— A fe…
RT @CAPR_AACR: Recently published #OnlineFirst: PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial— A fe…
RT @CAPR_AACR: Recently published #OnlineFirst: PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial— A fe…
Recently published #OnlineFirst: PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial— A feasibility study. @UoM_DCS @ProfEmmaCrosbie https://t.co/iCTtUGogln https://t.co/kHiyQ9P5sZ
RT @ECTeamSMH: Exciting new paper from @ProfEmmaCrosbie , #TeamWomb & colleagues reporting the feasibility of using levonorgestrel-intraute…
RT @ECTeamSMH: Exciting new paper from @ProfEmmaCrosbie , #TeamWomb & colleagues reporting the feasibility of using levonorgestrel-intraute…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @maureen_busby: Women with #obesity please 🙏 congratulations much needed
RT @ECTeamSMH: Exciting new paper from @ProfEmmaCrosbie , #TeamWomb & colleagues reporting the feasibility of using levonorgestrel-intraute…
PROgesterone Therapy for Endometrial Cancer protection in obese women (PROTEC) trial: a feasibility study | Cancer Prevention Research https://t.co/f1363Opw5x
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
Exciting new paper from @ProfEmmaCrosbie , #TeamWomb & colleagues reporting the feasibility of using levonorgestrel-intrauterine system for #endometrial PROTECtion in women with high BMI (>40kg/m2) #Clinicaltrial #endometrialcancer #preventionbette
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
RT @ProfEmmaCrosbie: Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endom…
Another publication from #Teamwomb! Well done @ProfEmmaCrosbie and team! @ManchesterBRC @FBMH_UoM @MFT_SMH @UoM_DCS @OfficialUoM
👏 Huge congratulations to @ProfEmmaCrosbie and #teamwomb 👏
Thrilled to announce publication of the PROTEC trial in @AACR today, demonstrating the feasibility of a primary #endometrial #cancer prevention trial. Congrats Abi & #TeamWomb! #PreventionBetterThanCure https://t.co/L0U4QIzV3X https://t.co/9BXOF5IOEo